Methyl 10-(2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)-9-methoxy-3-oxo-3h-benzo[f]chromene-2-carboxylate
Title | Journal |
---|---|
Proteomic approaches in understanding action mechanisms of metal-based anticancer drugs. | Metal-based drugs 20080101 |
Biochemical and proteomics approaches to characterize topoisomerase IIalpha cysteines and DNA as targets responsible for cisplatin-induced inhibition of topoisomerase IIalpha. | Molecular pharmacology 20050301 |